Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Biodesix (BDSX) Long-Term Debt Issuances (2019 - 2022)

Historic Long-Term Debt Issuances for Biodesix (BDSX) over the last 4 years, with Q4 2022 value amounting to $30.0 million.

  • Biodesix's Long-Term Debt Issuances changed N/A to $30.0 million in Q4 2022 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2023, which is 7782.8% down from last year.
  • Per Biodesix's latest filing, its Long-Term Debt Issuances stood at $30.0 million for Q4 2022.
  • Biodesix's Long-Term Debt Issuances' 5-year high stood at $30.0 million during Q1 2021, with a 5-year trough of $78000.0 in Q2 2021.
  • In the last 4 years, Biodesix's Long-Term Debt Issuances had a median value of $6.5 million in 2020 and averaged $11.4 million.
  • Data for Biodesix's Long-Term Debt Issuances shows a peak YoY increase of 1912948.72% (in 2022) and a maximum YoY decrease of 9965.67% (in 2022) over the last 5 years.
  • Over the past 4 years, Biodesix's Long-Term Debt Issuances (Quarter) stood at $3.0 million in 2019, then skyrocketed by 115.05% to $6.5 million in 2020, then tumbled by 98.81% to $78000.0 in 2021, then surged by 38361.54% to $30.0 million in 2022.
  • Its Long-Term Debt Issuances was $30.0 million in Q4 2022, compared to $15.0 million in Q2 2022 and $103000.0 in Q1 2022.